checkAd

HBM Healthcare Investments Quarterly Report December 2021

HBM Healthcare Investments AG / Key word(s): Quarter Results
HBM Healthcare Investments Quarterly Report December 2021

21-Jan-2022 / 06:46 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


HBM Healthcare Investments generated a net profit of CHF 4 million in the reporting quarter ended 31 December 2021. For the first nine months of the 2021/2022 financial year, the net profit amounts to CHF 275 million. Although the biotech stock market in general declined, several portfolio companies announced operational successes, which resulted in higher valuations. With cash and cash equivalents of CHF 226 million, HBM Healthcare is well positioned for a market downturn and may benefit from buying opportunities at low valuations. Eight new investments in private companies complement the portfolio. 

HBM Healthcare Investments closed the third quarter of the 2021/2022 financial year with a small net profit of CHF 4 million amid a bearish market environment, at least in the biotech sector. The net asset value per share (NAV) increased by 0.2 percent during the same period, while the share price declined by 0.3 percent.

This results in a profit of CHF 275 million for the first nine months of the financial year and an increase in the NAV of 12.8 percent. 

Operational success as a basis for high valuations

The two private companies Swixx BioPharma and ConnectRN concluded financing rounds with new investors. Against the backdrop of the companies' very successful operational development, these led to an increase in the valuation of the two investments totalling CHF 72 million.

Swixx BioPharma announced the signing of an agreement for the exclusive distribution of Sanofi's prescription drugs in Eastern Europe. The company expects this to double its 2022 sales to over EUR 600 million and plans to expand its team to around 900 employees.

ConnectRN, the digital placement platform for nursing staff in the United States, increased its 2021 revenue organically by more than 240 percent and expects further growth in the current year.

Seite 1 von 5





0 Kommentare
Nachrichtenquelle: EQS Group AG
 |  139   |   |   

Schreibe Deinen Kommentar

Disclaimer

HBM Healthcare Investments Quarterly Report December 2021 HBM Healthcare Investments AG / Key word(s): Quarter Results HBM Healthcare Investments Quarterly Report December 2021 21-Jan-2022 / 06:46 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the …

Nachrichten des Autors

Titel
Titel
Titel
Titel